Delta-like ligand 3: A promising target against small cell lung cancer

Aging Med (Milton). 2024 May 28;7(3):283-286. doi: 10.1002/agm2.12311. eCollection 2024 Jun.

Authors

Xin Nie¹, Yu-Meng Tian¹, Yue Yuan¹, Lin Li¹

Affiliation

¹ Department of Medical Oncology Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences Beijing China.

Abstract

This commentary highlighted the current knowledge about novel DLL3-targeting agents for refractory small cell lung cancer.

© 2024 The Author(s). Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd.